How do the NF-κB defects (e.g. CYLD, TRAF3 aberrations) and the immune system defects (including MHC loss) lead to tumor formation, or immune evasion (e.g., via dysregulation of innate and adaptive immune responses) [79,80]? The gene discussed is NFKB1; the disease is neoplasm.